Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.
Important Notice: INSPECT will be unavailable due to scheduled system maintenance on Wednesday, October, 21, 2015 from 4:00 A.M. through 8:00 A.M. EST. We apologize for any inconvenience.
Pursuant to IC 35-48-7-8.1, all errant records must now be corrected and resubmitted within three (3) business days. All controlled substances dispensed, including zero reports, must be reported within three (3) business days.
Effective January 1, 2016, all errant records must be corrected and resubmitted within twenty-four (24) hours. Additionally, all controlled substances dispensed, including zero reports, must be reported within twenty-four (24) hours or by the close of the next business day if the dispenser is closed the day following the dispensing.
Dr. Eric Wright with the Indiana University Richard M. Fairbanks School of Public Health at IUPUI presented the final report, “The Indiana INSPECT Evaluation: Key Findings and Recommendations From A Descriptive Analysis of INSPECT Data,” to the Indiana Board of Pharmacy on Monday, March 9, 2015. The web link provides the full report that examined de-identified INSPECT and provider licensure data from Calendar Years 2011 to 2013. The data was analyzed to identify trends with controlled substance prescriptions, and the report includes, but is not limited to, analysis on dispensation patterns, doctor shopping and demographic characteristics of opioid prescribers.
In 2012, the Harold Rogers grant program funded the following study conducted by the Center for Health Policy at the IU Richard M. Fairbanks School of Public Health at IUPUI. The study evaluated the effectiveness of INSPECT and the impact it was making to reduce prescription drug abuse. The Center for Health Policy was solely responsible for analyzing the data and summarizing the findings from the research. The Indiana Professional Licensing Agency, the Indiana State Department of Health and the Attorney General’s Prescription Drug Abuse Prevention Task Force collaborated on this effort.
INSPECT is now sharing live data with Utah! - Indiana now shares data with 20 states.
Click here for more information on the below training opportunities or to reserve a space.
Currently INSPECT is waiting on grant funding before more regional training sessions are scheduled, however INSPECT offers practice, hospital and physician group trainings, free of charge. Please contact WWoodruff1@pla.in.gov if you would like more information or if you are interested in a private on-site training session for your group or practice. Private on-site training sessions cover the same material mentioned above and include the benefit of having a notary to register interested eligible applicants immediately.